NORPRAMIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Norpramin, and when can generic versions of Norpramin launch?
Norpramin is a drug marketed by Validus Pharms and is included in one NDA.
The generic ingredient in NORPRAMIN is desipramine hydrochloride. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the desipramine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Norpramin
A generic version of NORPRAMIN was approved as desipramine hydrochloride by ACTAVIS TOTOWA on June 5th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NORPRAMIN?
- What are the global sales for NORPRAMIN?
- What is Average Wholesale Price for NORPRAMIN?
Summary for NORPRAMIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 89 |
Clinical Trials: | 10 |
Patent Applications: | 1,509 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for NORPRAMIN |
What excipients (inactive ingredients) are in NORPRAMIN? | NORPRAMIN excipients list |
DailyMed Link: | NORPRAMIN at DailyMed |
![NORPRAMIN drug patent expirations Drug patent expirations by year for NORPRAMIN](/p/graph/s/t/NORPRAMIN-patent-expirations.png)
![Drug Prices for NORPRAMIN](/p/graph/drug-price/NORPRAMIN.png)
Recent Clinical Trials for NORPRAMIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Stanford University | Phase 4 |
Albert Einstein College of Medicine of Yeshiva University | N/A |
Albert Einstein College of Medicine | N/A |
Pharmacology for NORPRAMIN
Drug Class | Tricyclic Antidepressant |
US Patents and Regulatory Information for NORPRAMIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Validus Pharms | NORPRAMIN | desipramine hydrochloride | TABLET;ORAL | 014399-007 | Feb 11, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Validus Pharms | NORPRAMIN | desipramine hydrochloride | TABLET;ORAL | 014399-004 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Validus Pharms | NORPRAMIN | desipramine hydrochloride | TABLET;ORAL | 014399-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Validus Pharms | NORPRAMIN | desipramine hydrochloride | TABLET;ORAL | 014399-003 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Validus Pharms | NORPRAMIN | desipramine hydrochloride | TABLET;ORAL | 014399-006 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Validus Pharms | NORPRAMIN | desipramine hydrochloride | TABLET;ORAL | 014399-005 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NORPRAMIN
International Patents for NORPRAMIN
See the table below for patents covering NORPRAMIN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
France | 1445454 | Nouveaux dérivés d'iminodibenzyle et leur préparation | ⤷ Sign Up |
Spain | 267641 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |